Publication

Dynamics of Simian Immunodeficiency Virus SIVmac239 Infection in Pigtail Macaques

Downloadable Content

Persistent URL
Last modified
  • 03/05/2025
Type of Material
Authors
    Nichole R. Klatt, National Institutes of HealthLauren A. Canary, National Institutes of HealthThomas Vanderford, Emory UniversityCarol L. Vinton, National Institutes of HealthJessica C. Engram, Emory UniversityRichard M. Dunham, Emory UniversityHeather E. Cronise, National Institutes of HealthJoanna M. Swerczek, National Institutes of HealthBernard A. P. Lafont, National Institutes of HealthLouis J. Picker, Oregon Health & Science UniversityGuido Silvestri, Emory UniversityJason M. Brenchley, National Institutes of Health
Language
  • English
Date
  • 2012-01
Publisher
  • American Society for Microbiology
Publication Version
Copyright Statement
  • © 2012, American Society for Microbiology. All Rights Reserved.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0022-538X
Volume
  • 86
Issue
  • 2
Start Page
  • 1203
End Page
  • 1213
Grant/Funding Information
  • These studies were supported by the intramural program of the National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health, and in part by NIH grants R01-AI90797; to G. Silvestri and AI054292 to L. Picker as well as ONPRC Core grant RR00163.
Supplemental Material (URL)
Abstract
  • Pigtail macaques (PTM) are an excellent model for HIV research; however, the dynamics of simian immunodeficiency virus (SIV) SIVmac239 infection in PTM have not been fully evaluated. We studied nine PTM prior to infection, during acute and chronic SIVmac239 infections, until progression to AIDS. We found PTM manifest clinical AIDS more rapidly than rhesus macaques (RM), as AIDS-defining events occurred at an average of 42.17 weeks after infection in PTM compared to 69.56 weeks in RM (P=0.0018). However, increased SIV progression was not associated with increased viremia, as both peak and set-point plasma viremias were similar between PTM and RM (P=0.7953 and P=0.1006, respectively). Moreover, this increased disease progression was not associated with rapid CD4 + T cell depletion, as CD4 + T cell decline resembled other SIV/human immunodeficiency virus (HIV) models. Since immune activation is the best predictor of disease progression during HIV infection, we analyzed immune activation by turnover of T cells by BrdU decay and Ki67 expression. We found increased levels of turnover prior to SIV infection of PTM compared to that observed with RM, which may contribute to their increased disease progression rate. These data evaluate the kinetics of SIVmac239-induced disease progression and highlight PTM as a model for HIV infection and the importance of immune activation in SIV disease progression.
Author Notes
Keywords
Research Categories
  • Health Sciences, Immunology
  • Biology, Virology
  • Biology, Microbiology

Tools

Relations

In Collection:

Items